EUA
CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)
FDA Emergency Use Authorization · Centers for Disease Control and Prevention's (CDC) · Mar 7, 2023
Key facts
| Product | CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC) |
|---|---|
| Company | Centers for Disease Control and Prevention's (CDC) |
| Product type | Real-time RT-PCR, Pooling, Multiple Targets |
| Date | Mar 7, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: